Search

everythinglearnresearchcommunity

for

Search:↓

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Type I interferons play a key role in the development of various skin diseases.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

The document explains various skin conditions and their treatments.

Diabetes can cause a variety of skin disorders, some of which may signal more serious health issues.

Finasteride is effective for male hair loss, teledermatology is accurate and accepted, and cyclosporin helps treat toxic epidermal necrolysis.

Manage vitiligo with treatments, address emotions, and use camouflage techniques.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Lowering testosterone speeds up wound healing in male mice.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Some medications can cause acne, and stopping these drugs is the main treatment.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

Inflammation plays a key role in activating skin stem cells for hair growth and wound healing, but more research is needed to understand how it directs cell behavior.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

A new non-invasive method can analyze skin mRNA to understand skin diseases better.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.